Start the conversation
I first unveiled this "baby biotech" to my Private Briefing subscribers in our very first publication.
And it's been a huge winner for them since then.
Your "win" was extended by a big day last Wednesday when bullish news about a drug this company is working on with partner Gilead Sciences Inc. (NASDAQ: GILD) shot our stock up 16.5%.
In short, the stock I'm showing you today is a proverbial "10-Bagger" - the Holy Grail of stock picking. Heck, it almost became a "13-Bagger."
This is actually the third "10-Bagger" we've brought you in the seven years we've been blessed to be your market guide.
So let's take a look...
About the Author
Before he moved into the investment-research business in 2005, William (Bill) Patalon III spent 22 years as an award-winning financial reporter, columnist, and editor. Today he is the Executive Editor and Senior Research Analyst for Money Morning at Money Map Press.